Bristol-Myers Squibb has launched its infant nutrition unit, Mead Johnson Nutrition Co., onto the New York Stock Exchange, raising US$720m.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

In a statement, Bristol-Myers said cash from the Mead Johnson initial public offering will be used to strengthen its capital structure and invest in its biopharma business.


The company sold 30m shares at US$24 per share yesterday (10 February).


Bristol-Myers has retained an 85% stake in Mead Johnson.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.